Rankings
▼
Calendar
SCYX Q4 2021 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena
SCYX
SCYNEXIS, Inc.
$38M
Q4 2021 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$597,000
Gross Profit
$430,000
72.0% margin
Operating Income
-$22M
-3734.8% margin
Net Income
-$29M
-4898.3% margin
EPS (Diluted)
$-1.05
QoQ Revenue Growth
+15.7%
Cash Flow
Operating Cash Flow
-$26M
Free Cash Flow
-$26M
Stock-Based Comp.
$560,000
Balance Sheet
Total Assets
$120M
Total Liabilities
$79M
Stockholders' Equity
$41M
Cash & Equivalents
$104M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$597,000
$0
—
Gross Profit
$430,000
$0
—
Operating Income
-$22M
-$15M
-45.4%
Net Income
-$29M
-$43M
+31.5%
Revenue Segments
Product
$597,000
100%
← FY 2021
All Quarters
Q1 2022 →